Cargando…

Novel Cancer Immunotherapies and Antitumor Immunity

Detalles Bibliográficos
Autores principales:	Zhao, Lei, Zhang, Jianjun, Xu, Liang, Abbas, Hussein A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679854/ https://www.ncbi.nlm.nih.gov/pubmed/31428655 http://dx.doi.org/10.1155/2019/3742061

Ejemplares similares

Cancer Immunology and Immunotherapies: Mechanisms That Affect Antitumor Immune Response and Treatment Resistance
por: Zhao, Xianda, et al.
Publicado: (2021)

Creatine in T Cell Antitumor Immunity and Cancer Immunotherapy
por: Li, Bo, et al.
Publicado: (2021)

KALRN mutations promote antitumor immunity and immunotherapy response in cancer
por: Li, Mengyuan, et al.
Publicado: (2020)

Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
por: Dai, Enyong, et al.
Publicado: (2021)

Identification of immune-related subtypes of colorectal cancer to improve antitumor immunotherapy
por: Zheng, Xiaobo, et al.
Publicado: (2021)

Neoadjuvant chemo-immunotherapy for lung cancer: how much is too much?
por: Deboever, Nathaniel, et al.
Publicado: (2022)

Antitumor and Adjuvant Activity of λ-carrageenan by Stimulating Immune Response in Cancer Immunotherapy
por: Luo, Min, et al.
Publicado: (2015)

JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy
por: McGraw, Joseph M., et al.
Publicado: (2021)

Immune Evasion as the Main Challenge for Immunotherapy of Cancer
por: Zagozdzon, Radoslaw, et al.
Publicado: (2022)

Cancer Immunotherapy: Harnessing the Immune System to Fight Cancer
por: Rizzo, Alessandro, et al.
Publicado: (2022)

A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy
por: Sinha, Uttam K., et al.
Publicado: (2023)

Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity
por: Liang, Jingjing, et al.
Publicado: (2020)

Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
por: Schaaf, Marco B., et al.
Publicado: (2018)

Lung cancer treatment in the era of immunotherapy
por: Xu, Yang, et al.
Publicado: (2020)

Tumor Immune Microenvironments (TIMEs): Responsive Nanoplatforms for Antitumor Immunotherapy
por: Sui, Xueqing, et al.
Publicado: (2020)

Epigenetic modulation of the tumor immune microenvironment by nanoinducers to potentiate cancer immunotherapy
por: Zhang, Ning, et al.
Publicado: (2022)

Neutrophils and anti-cancer immunity: a paradigm shift in cancer immunotherapy
por: Sturey, Rebecca, et al.
Publicado: (2017)

Targeting Innate Immune Cells for Immunotherapy
por: Carreño, Leandro J., et al.
Publicado: (2017)

Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
por: Gong, Ruining, et al.
Publicado: (2021)

Harnessing the antitumor potential of macrophages for cancer immunotherapy
por: Long, Kristen B, et al.
Publicado: (2013)

Kinetics reshape antitumor immunity: Timing, duration, and combination are of importance for successful cancer immunotherapy
por: Jin, Seung Mo, et al.
Publicado: (2023)

T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
por: Schmid, Daniela, et al.
Publicado: (2017)

Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity
por: Perry, Curtis J., et al.
Publicado: (2018)

Using triple radio-immunotherapy to overcome cancer immunotherapy resistance
por: Zhang, Zengfu, et al.
Publicado: (2023)

Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
por: Liu, Xia, et al.
Publicado: (2022)

The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy
por: Zhang, Yuanling, et al.
Publicado: (2023)

Mucosal Immunity and Sublingual Immunotherapy in Respiratory Disorders
por: Bahceciler, Nerin N.
Publicado: (2012)

Cancer immunotherapy
por: Yan, Li, et al.
Publicado: (2014)

Harnessing the soil: reshaping the tumor microenvironment towards an antitumor immune state by low‐dose metformin
por: Lin, Yusheng, et al.
Publicado: (2021)

Harnessing Antitumor CD4(+) T Cells for Cancer Immunotherapy
por: Ben Khelil, Myriam, et al.
Publicado: (2022)

Combination of immune checkpoint blockade and targeted gene regulation of angiogenesis for facilitating antitumor immunotherapy
por: Zhan, Jing, et al.
Publicado: (2023)

WT1 as an immunotherapy target for thymic epithelial tumors: a novel method to activate anti-tumor immunity
por: Takahashi, Nobuyuki, et al.
Publicado: (2019)

The importance of examining an active immune system during immunotherapy
por: Gibson, Heather M., et al.
Publicado: (2019)

Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
por: Bahmani, Baharak, et al.
Publicado: (2021)

Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy
por: Song, Chang, et al.
Publicado: (2014)

Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy
por: Van Acker, Heleen H, et al.
Publicado: (2015)

Editorial of the Special Issue: Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer
por: Guo, Zong Sheng, et al.
Publicado: (2017)

Cancer Immunology and Immunotherapy
por: Owais, Mohammad, et al.
Publicado: (2015)

Gastroenterological Cancer and Immunotherapy
por: Wang, Xiaoping, et al.
Publicado: (2018)

Nanomedicine and cancer immunotherapy
por: Yu, Hai-jun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j607f0k3mb7op07ot6svv61gs6